Daiichi Sankyo Pharma Development
Manufacturer Details
There are currently no manufacturer details available.
Daiichi Sankyo Pharma Development Drugs
-
![Evoxac (Cevimeline Hydrochloride) Capsule [Daiichi Sankyo Pharma Development]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=0679dd4c-fece-4c6d-b273-2c62237e8973&name=evoxac-figure-2.jpg)
Evoxac
The recommended dose of cevimeline hydrochloride is 30 mg taken three times a day. There is insufficient safety information to support doses greater than 30 mg tid. There is also insufficient evidence for additional efficacy of cevimeline hydrochloride at doses greater than 30 mg tid.
Sign Up for a Free Account